A1c Below ADA Target in Six Months: New Nourish Data Shows the Impact of Dietitian-Led Care on Blood Sugar for Adults with Diabetes
.jpg)
- In a newly presented study of patients with type 2 diabetes, Nourish care was associated with a clinically meaningful improvement in blood sugar, with average A1c falling 1.37 points after six months.
- Among participants who started with an A1c of 7.0% or higher, more than half were able to drop below 7.0% after six months, which is the ADA-recommended target for glycemic control.
- These improvements were observed across multiple medication profiles, including in adults with no GLP-1 exposure. With GLP-1s dominating the conversation, this data suggests dietitian-led care contributes to improved blood sugar beyond medication alone.
- Type 2 diabetes affects around 1 in 10 U.S. adults and is a leading driver of preventable morbidity. These results demonstrate the effectiveness of the Nourish care model in driving outcomes for patients, providing an accessible, insurance-covered path to care.
Nourish, the country's largest dietitian-led metabolic health clinic, presented results from a new real-world study this week at ObesityWeek, the premier conference focused on obesity research, treatment, prevention, and public policy. Among more than 2,000 adults with type 2 diabetes who stayed engaged in Nourish care for six months, working with a registered dietitian was associated with a clinically meaningful improvement in blood sugar.
Key findings
- 1.37 point A1c reduction: Steady improvement in A1c yielded a 1.15 point reduction after three months, and an average total reduction of 1.37 points after six months
- Improvement in adults not on GLP-1s: Results from this study were observed across medication profiles, including among adults with no GLP-1 exposure
To put that 1.37-point reduction in context, existing literature suggests that each percentage-point of improved A1c is associated with a 21% lower relative risk of diabetes-related complications, and a 37% lower relative risk of microvascular disease. These numbers are encouraging, given that type 2 diabetes affects around 1 in 10 U.S. adults and is a leading driver of preventable morbidity in this country.
While medical nutrition therapy is a recommended part of the management of type 2 diabetes, real-world evidence on outcomes from virtual care models remains limited. These results suggest that dietitian-led care contributes to improvements in blood sugar beyond concurrent medication use.
The retrospective analysis presented by the Nourish clinical research team included adults with type 2 diabetes who had at least one follow-up A1c measurement, and remained engaged in care over the course of six months (n=2,444). At Nourish, a registered dietitian serves as the entry point to care for all patients, with AI-powered support between visits.
“While GLP-1s have captured much of the attention in diabetes care, effective treatment goes well beyond any single medication,” said Nourish CMO Dr. Ajay Haryani. “Regardless of a patient’s medication regimen, consistent, longitudinal support from a Registered Dietitian is essential to improving glycemic control and sustaining those improvements over time. Our data showed that more than half of patients who started above the ADA’s glycemic target achieved that target within six months. It’s a powerful case for making nutrition care a foundational part of diabetes treatment for every patient.”
For more detail, see the poster here.





